CClinicalTrials.gg
RecruitingNCT07057362Updated Jan 6, 2026

Effect of Vitamin D Deficiency on the Frequency and Severity of Spinal Anesthesia-Induced Hypotension in Pregnant Women Undergoing Cesarean Section

An observational study in Spinal Anesthesia-induced Hypotension, Vitamin D Deficiency and Cesarean Section, sponsored by Duzce University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-01-06.

Sponsored by Duzce University · Observational

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
140
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

Spinal anesthesia-induced hypotension remains a common and significant complication during cesarean sections, posing risks for both mother and fetus. Vitamin D deficiency, frequently observed in pregnant women, is associated with altered vascular function and potential hemodynamic instability. This prospective observational study aims to investigate whether vitamin D deficiency is associated with an increased incidence and severity of spinal anesthesia-induced hypotension in pregnant women undergoing elective cesarean delivery. Vitamin D levels will be measured preoperatively, and intraoperative hemodynamic parameters will be closely monitored. The findings could contribute to improved management strategies for pregnant patients at risk of severe hypotension.

Read the detailed description

Detailed Description Spinal anesthesia is the most commonly used technique for cesarean section and is associated with a high incidence of maternal hypotension, which can adversely affect both maternal well-being and neonatal outcomes. Despite standard preventive strategies such as fluid preloading and vasopressor use, significant hypotension still occurs in a considerable proportion of patients.

Vitamin D deficiency is a prevalent condition among pregnant women and has been implicated in the modulation of cardiovascular and autonomic functions. Low serum levels of 25-hydroxyvitamin D may impair vascular smooth muscle contractility, endothelial function, and baroreflex sensitivity, potentially contributing to exaggerated hypotensive responses under spinal anesthesia.

This prospective observational study aims to evaluate the relationship between maternal vitamin D status and the incidence and severity of spinal anesthesia-induced hypotension during elective cesarean delivery. Eligible pregnant women scheduled for elective cesarean section under spinal anesthesia will have their serum 25-hydroxyvitamin D levels measured preoperatively. Intraoperative hemodynamic parameters will be continuously monitored, and episodes of hypotension will be recorded and analyzed in relation to vitamin D status.

The primary outcome of the study is the incidence of spinal hypotension, defined as a ≥20% decrease in systolic blood pressure from baseline or an absolute value below 90 mmHg. Secondary outcomes include total vasopressor dose, fluid requirement.

Findings from this study may identify vitamin D deficiency as a novel risk factor for spinal anesthesia-induced hypotension and inform new preventive strategies for hemodynamic management in cesarean deliveries

02

Conditions studied

  • Spinal Anesthesia-induced Hypotension
  • Vitamin D Deficiency
  • Cesarean Section

Browse trials for

03

In context

Vitamin D Deficiency

772 studies on the registry are indexed under Vitamin D Deficiency; 61 are open to participants now.

This study's planned enrollment of 140 is close to the median of 138 across 183 observational studies indexed under Vitamin D Deficiency.

Browse Vitamin D Deficiency studies →

Lead sponsor

Duzce University is the lead sponsor of 70 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Pregnant women aged 18 years and older who are scheduled for elective cesarean section under spinal anesthesia at a tertiary care university hospital. All participants will be clinically stable and provide informed consent prior to enrollment. The study population will be stratified based on serum vitamin D levels into deficient and sufficient groups for analysis of hypotension outcomes.

Inclusion criteria

  • Pregnant women aged 18 years or older
  • Scheduled for elective cesarean delivery under spinal anesthesia
  • Able and willing to provide written informed consent

Exclusion criteria

Exclusion Criteria:

  • Emergency cesarean sections
  • History of significant cardiovascular disease (e.g., arrhythmia, heart failure)
  • Known neurological disorders affecting autonomic function
  • Current vitamin D supplementation within the past 30 days
  • Inability to undergo blood sampling or provide valid hemodynamic data
  • Contraindication to spinal anesthesia
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
140 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Vitamin D Deficient Group

    Pregnant women with serum 25-hydroxyvitamin D levels below the defined deficiency threshold

    Other: Intraoperative Hemodynamic Monitoring

  • Vitamin D Sufficient Grup

    Pregnant women with normal or sufficient vitamin D levels

    Other: Intraoperative Hemodynamic Monitoring

Interventions

  • OtherIntraoperative Hemodynamic Monitoring

    Continuous intraoperative monitoring of systolic blood pressure and heart rate following spinal anesthesia. Vasopressor usage and total fluid administration will be recorded.

06

What researchers measure

Primary outcomes

  1. Incidence of Hypotension After Spinal Anesthesia

    Hypotension is defined as a ≥20% decrease in systolic blood pressure from baseline or an absolute systolic value \<90 mmHg. The presence or absence of hypotension will be recorded.

    Time frame: ntraoperative (0-30 minutes after spinal anesthesia)

Secondary outcomes

  1. Total Vasopressor Dose Administered

    Cumulative amount (in mg) of vasopressor (e.g., ephedrine or phenylephrine) used to manage hypotension.

    Time frame: Intraoperative (0-30 minutes after spinal anesthesia)

  2. Total Crystalloid Volume Administered

    Total amount (in mL) of intravenous crystalloids given from the time of spinal anesthesia until delivery.

    Time frame: Intraoperative (0-30 minutes after spinal anesthesia)

07

Study locations

1 of 1 sites recruiting
  • Duzce University Faculty of Medicine, Department of Anesthesiology and Reanimation
    Düzce, Merkez, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — The study involves sensitive clinical data from pregnant women. Individual participant data will not be shared publicly due to privacy concerns.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07057362
Lead sponsor
Duzce University
Responsible party
Sponsor
First posted
Jul 9, 2025
Start date
Mar 1, 2025
Primary completion
Dec 30, 2025
Completion
Dec 30, 2025 (estimated)
Last update
Jan 6, 2026

Study contacts

Gizem DEMIR SENOGLU
Contact
gizem123demir@hotmail.com
+905059313588

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion